J2507 HCPCS code: Injection, pegloticase, 1 mg
J2507 is the HCPCS Level II code for injection, pegloticase, 1 mg. In 2024 Medicare paid an average of $2,636.03 per service for J2507 across 73,733 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 8 per day on outpatient hospital claims. Medicare volume rose 26% from 2022 to 2024 (58,508 to 73,733 services). In 2024, about 825 clinicians billed Medicare for J2507 for 957 beneficiaries; Florida, Texas, California accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2012-01-01 |
| Last action effective | 2012-01-01 |
Who bills J2507 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 825 |
| Medicare beneficiaries | 957 |
| States with claims | 25 |
| Share of services in top 3 states (Florida, Texas, California) | 32% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2507, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 58,508 | 834 | $2,912.05 | $2,324.06 |
| 2023 | 69,327 | 952 | $3,097.34 | $2,467.56 |
| 2024 | 73,733 | 957 | $3,306.82 | $2,636.03 |
States with the most J2507 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 8,306 | $2,660.11 |
| Texas | 7,714 | $2,678.12 |
| California | 6,113 | $2,388.37 |
| Maryland | 5,541 | $2,638.97 |
| Arizona | 3,765 | $2,684.83 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 8 | Prescribing Information |
| practitioner claims | 8 | Prescribing Information |
What changed for J2507
- 2012-01-01: J2507 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2507?
J2507 is the HCPCS Level II code for injection, pegloticase, 1 mg. Short descriptor: "Pegloticase injection".
How much does Medicare pay for J2507?
In 2024, the average Medicare payment was $2,636.03 per service (average allowed $3,306.82).
Does Medicare cover J2507?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2507 can be billed per day?
8 on outpatient hospital claims; 8 on practitioner claims (NCCI medically unlikely edits).
Related J25 codes
- J2501 — Injection, paricalcitol, 1 mcg
- J2502 — Injection, pasireotide long acting, 1 mg
- J2503 — Injection, pegaptanib sodium, 0.3 mg
- J2504 — Injection, pegademase bovine, 25 iu
- J2505 — Injection, pegfilgrastim, 6 mg
- J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2508 — Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510 — Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2513 — Injection, pentastarch, 10% solution, 100 ml
- J2515 — Injection, pentobarbital sodium, per 50 mg
- J2516 — Injection, pentamidine isethionate, 1 mg
- J2540 — Injection, penicillin g potassium, up to 600,000 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2507
- Watch J2507 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2507
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.